ATE397439T1 - Zubereitung zur kontinuierlichen arzneimittelfreisetzung chitosan enthaltend - Google Patents

Zubereitung zur kontinuierlichen arzneimittelfreisetzung chitosan enthaltend

Info

Publication number
ATE397439T1
ATE397439T1 AT05003405T AT05003405T ATE397439T1 AT E397439 T1 ATE397439 T1 AT E397439T1 AT 05003405 T AT05003405 T AT 05003405T AT 05003405 T AT05003405 T AT 05003405T AT E397439 T1 ATE397439 T1 AT E397439T1
Authority
AT
Austria
Prior art keywords
preparation containing
release preparation
containing chitosan
continuous medicinal
medicinal release
Prior art date
Application number
AT05003405T
Other languages
English (en)
Inventor
Adnan Dr Badwan
Mayyas Mohammad Ahma Al-Remawi
Murshed Abdel-Qader M Mohammed
Original Assignee
Jordanian Pharmaceutical Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jordanian Pharmaceutical Mfg filed Critical Jordanian Pharmaceutical Mfg
Application granted granted Critical
Publication of ATE397439T1 publication Critical patent/ATE397439T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05003405T 2005-02-17 2005-02-17 Zubereitung zur kontinuierlichen arzneimittelfreisetzung chitosan enthaltend ATE397439T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05003405A EP1693051B1 (de) 2005-02-17 2005-02-17 Zubereitung zur kontinuierlichen Arzneimittelfreisetzung Chitosan enthaltend

Publications (1)

Publication Number Publication Date
ATE397439T1 true ATE397439T1 (de) 2008-06-15

Family

ID=34933799

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05003405T ATE397439T1 (de) 2005-02-17 2005-02-17 Zubereitung zur kontinuierlichen arzneimittelfreisetzung chitosan enthaltend

Country Status (16)

Country Link
US (1) US20100130612A1 (de)
EP (2) EP1693051B1 (de)
JP (1) JP2008530148A (de)
KR (1) KR20070104643A (de)
CN (1) CN101128183A (de)
AP (1) AP2007004156A0 (de)
AT (1) ATE397439T1 (de)
AU (1) AU2005327852A1 (de)
BR (1) BRPI0520078A2 (de)
CA (1) CA2598364A1 (de)
DE (1) DE602005007319D1 (de)
EA (1) EA200701735A1 (de)
MA (1) MA29317B1 (de)
TN (1) TNSN07288A1 (de)
WO (1) WO2006087028A1 (de)
ZA (1) ZA200706807B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1955711A1 (de) * 2007-02-09 2008-08-13 The Jordanian Pharmaceutical Manufacturing Co. Kovalente Konjugate aus Chitosan und einem sauren Wirkstoff enthaltende Zusammensetzung zur parenteralen Verabreichung
EP1955693A1 (de) * 2007-02-09 2008-08-13 The Jordanian Pharmaceutical Manufacturing Co. Zusammensetzung, die Chitosan und eine säurehaltige Substanz umfasst, zur oral gesteuerten Freisetzung
DE102009024542A1 (de) * 2009-06-10 2010-12-16 Arivine Pharma Ag Zusammensetzungen auf Basis von Chitosan-Oligosacchariden

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8608890A1 (es) * 1985-09-16 1986-09-01 Carulla Vekar S A Preparado farmaceutico liquido a base de teofilina de efec- tos retardados y procedimiento para su obtencion
JPH05339149A (ja) * 1992-02-27 1993-12-21 Taisho Pharmaceut Co Ltd 徐放性懸濁製剤
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
JP3605613B2 (ja) * 2001-10-01 2004-12-22 有限会社関西キトサン 植物栽培用液剤
GB0302738D0 (en) * 2003-02-06 2003-03-12 Advanced Biopolymers As Composition

Also Published As

Publication number Publication date
EP1693051B1 (de) 2008-06-04
EP1848397A1 (de) 2007-10-31
CA2598364A1 (en) 2006-08-24
WO2006087028A1 (en) 2006-08-24
TNSN07288A1 (en) 2008-12-31
DE602005007319D1 (de) 2008-07-17
CN101128183A (zh) 2008-02-20
AP2007004156A0 (en) 2007-10-31
EP1693051A1 (de) 2006-08-23
AU2005327852A1 (en) 2006-08-24
JP2008530148A (ja) 2008-08-07
BRPI0520078A2 (pt) 2009-04-14
KR20070104643A (ko) 2007-10-26
ZA200706807B (en) 2008-10-29
US20100130612A1 (en) 2010-05-27
EA200701735A1 (ru) 2008-02-28
MA29317B1 (fr) 2008-03-03

Similar Documents

Publication Publication Date Title
HK1125295A1 (en) Microtablet-based pharmaceutical preparation
PL1957073T3 (pl) Substancja lecznicza
PL2086458T3 (pl) System do higieny jamy ustnej
ZA200801275B (en) Pharmaceutical preparation containing meloxicam
EP1992348A4 (de) Pharmazeutische kombination
ZA200705530B (en) Sustained release pharmaceutical formulations
ZA200709490B (en) Breath actuated drug delivery system
EP1895991A4 (de) Formulierungen mit modifizierter freisetzung von arzneimitteln gegen erregbarkeit
ZA200901666B (en) Fillings
EP1834652A4 (de) Herstellung einer dialyse
PL2002828T3 (pl) Stały preparat farmaceutyczny
EP2002777A4 (de) Medizinisches system
IL198160A0 (en) Pharmaceutical formulations
ATE397439T1 (de) Zubereitung zur kontinuierlichen arzneimittelfreisetzung chitosan enthaltend
ZA200707910B (en) Contraceptive pharmaceutical preparation
EP1864664A4 (de) Pharmazeutische zubereitung
TWI372053B (en) Combination drug
EP1716865A4 (de) Paraoxonase-haltige pharmazeutische zubereitung
BRPI0906346A2 (pt) "composição farmacêutica de liberação prolongada"
PL1915137T3 (pl) Preparat doustny o kontrolowanym uwalnianiu
BRPI0719394A2 (pt) Preparação medicinal sólida
GB0505779D0 (en) Drug release system
PL380476A1 (pl) Preparat farmaceutyczny
PL378648A1 (pl) Preparat farmaceutyczny oraz sposób jego otrzymywania
FI20060582A0 (fi) Farmaseuttinen valmiste

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties